The novel therapy of this peptide represents a exciting development in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – providing greater blood sugar regulation and potential reduction in weight. R